Occudo Quantitative Strategies LP Eye Point Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $183,724 - $776,406	32,176 New	32,176 $743,000
Q2 2023 Aug 14, 2023	SELL	$3.03 - $9.0 $64,296 - $190,980	-21,220 Reduced 58.46%	15,078 $131,000
Q1 2023 May 15, 2023	BUY	$2.28 - $5.04 $35,401 - $78,256	15,527 Added 74.75%	36,298 $106,000
Q4 2022 Feb 14, 2023	BUY	$2.37 - $7.2 $49,227 - $149,551	20,771 New	20,771 $72,000

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.